Advertisement
News
Subscribe to MDT Magazine News

Summary Box: Community Health makes new Tenet bid

April 18, 2011 7:45 am | by The Associated Press | Comments

TAKE TWO: Hospital operator Community Health Systems Inc. revised its bid for Tenet Healthcare Corp. Monday and is now proposing a deal worth about $3 billion in cash.THE CHANGE: The offer still values Tenet at $6 per share. Community Health had offered to buy Tenet for $5 per share in cash and...

BB & T Advises Dr. Comfort on Its Sale to DJO Global in Transaction Valued at $254.6 Million

April 18, 2011 6:38 am | by Bio-Medicine.Org | Comments

RICHMOND, Va., April 18, 2011 /- BB&T Capital Markets served as the exclusive financial advisor to Rikco International LLC, d/b/a Dr. Comfort, the leading developer, manufacturer and marketer of therapeutic footwear and related medical and comfort products, in its sale to DJO Global,...

TOPICS:

Australian Center Readies Brain Research Program for Addition of Elekta MEG System

April 18, 2011 6:36 am | by Bio-Medicine.Org | Comments

MELBOURNE, Australia, April 18, 2011 /- Certain brain processes happen in the blink of an eye – and even faster – which has made pinpointing these events virtually impossible. The advent of magnetoencephalography (MEG) changed all that, enabling researchers to capture brain...

TOPICS:
Advertisement

Symmetry Medical to Report First Quarter 2011 Financial Results on May 5, 2011

April 18, 2011 6:35 am | by Bio-Medicine.Org | Comments

WARSAW, Ind., April 18, 2011 /- Symmetry Medical Inc. (NYSE: SMA ), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today that it will release first quarter 2011 financial results for the period ending April 2, 2011...

TOPICS:

CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation

April 18, 2011 6:35 am | by Bio-Medicine.Org | Comments

ATLANTA and IRVINE, Calif., April 18, 2011 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, today announced the expiration of the 20-day "go-shop" period that is part of its definitive agreement with Cardiogenesis...

TOPICS:

Sigma-Tau Pharmaceuticals Announces Approval for New Manufacturing Process for ONCASPAR® (Pegaspargase) Primary Ingredient

April 18, 2011 6:34 am | by Bio-Medicine.Org | Comments

GAITHERSBURG, Md., April 18, 2011 /- Sigma-Tau Pharmaceuticals, Inc. is pleased to announce that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture L-asparaginase, the primary ingredient in the oncology medicine ONCASPAR® (pegaspargase)....

TOPICS:

InstaCare Subsidiary Signs New Agreement for Expanded Management and Sales of Shasta Genstrip Into the $20 Billion Worldwide Diabetes Testing Market

April 18, 2011 6:32 am | by Bio-Medicine.Org | Comments

LOS ANGELES, April 18, 2011 /- InstaCare Corp. (OTCQB: ISCR) a leading provider of prescription diagnostics, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary cell phone centric e...

TOPICS:

Community Health makes all-cash bid for Tenet

April 18, 2011 4:45 am | by The Associated Press | Comments

Hospital operator Community Health Systems Inc. is revising its $3 billion offer for rival Tenet Healthcare Corp. to an all-cash bid.The offer values Tenet at $6 per share. In December, Community Health Systems went public with a bid of $5 per share in cash and $1 per share in stock. At the...

Advertisement

University of Virginia Installs First Two TomoTherapy(R) TomoHD(TM) Systems in U.S.

April 18, 2011 4:45 am | by The Associated Press | Comments

http://www.tomotherapy.com () —TomoTherapy Incorporated (http://www.tomotherapy.com) (NASDAQ: TOMO), maker of advanced radiation therapy solutions for the treatment of cancer and other diseases, today announced that two of the first TomoTherapy@ TomoHD treatment systems in the United States...

AIDS prevention pill study halted; no benefit seen

April 18, 2011 4:45 am | by MARILYNN MARCHIONE - AP Medical Writer - Associated Press | Comments

Researchers are stopping a study testing a daily pill to prevent infection with the AIDS virus in thousands of African women.Partial results show that women taking Truvada (true-VAH'-duh), made by Gilead Sciences Inc., are just as likely to get HIV as other women who take dummy pills.Even if the...

Questcor to Report First Quarter 2011 Earnings and Conduct Conference Call on April 26, 2011

April 18, 2011 3:36 am | by Bio-Medicine.Org | Comments

ANAHEIM, Calif., April 18, 2011 /- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR ) today announced that it will release first quarter 2011 financial results on Tuesday, April 26, 2011 after the close of the U.S. financial markets.  The Company will host a conference call and webcast...

TOPICS:

Lilly Reports First-Quarter 2011 Results

April 18, 2011 3:36 am | by Bio-Medicine.Org | Comments

INDIANAPOLIS, April 18, 2011 /- First quarter 2011 revenue grew 6 percent to $5.8 billion, driven by increased demand in international markets. Company delivered first quarter earnings per share of $.95 (reported), or $1.24 (non-GAAP). 2011 non-GAAP earnings per share guidance range...

TOPICS:

PDL BioPharma to Hold Annual Meeting of Stockholders on June 22, 2011

April 18, 2011 3:36 am | by Bio-Medicine.Org | Comments

INCLINE VILLAGE, Nev., April 18, 2011 /- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) today announced that the company will hold its annual meeting of stockholders on Wednesday, June 22, 2011 at 10:00 a.m. Pacific Time for all stockholders of record on April 25, 2011. The meeting will take...

TOPICS:

Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors

April 18, 2011 3:36 am | by Bio-Medicine.Org | Comments

MISSISSAUGA, Ontario, April 18, 2011 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) today filed a revised preliminary consent solicitation statement in which it named Mr. Abe M. Friedman to its slate of proposed directors in connection with its previously announced...

TOPICS:

TRTB to Launch Blue Diamond Pill Targeting Ethnic Market With Sexual Enhancement Pills

April 18, 2011 2:36 am | by Bio-Medicine.Org | Comments

LOS ANGELES, April 18, 2011 /- True 2 Beauty Inc., (Pinksheets: TRTB - News ) (the "Company") ( www.true2beautyinc.com ), a leading distributor of male and female sexual potency pills and liquid products in the United States, is pleased to announce the launch of a new, additional line of...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading